Cargando…
High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
Despite significant advancements in breast cancer (BC) research, clinicians lack robust serological protein markers for accurate diagnostics and tumor stratification. Tumor interstitial fluid (TIF) accumulates aberrantly externalized proteins within the local tumor space, which can potentially gain...
Autores principales: | Terkelsen, Thilde, Pernemalm, Maria, Gromov, Pavel, Børresen‐Dale, Anna‐Lise, Krogh, Anders, Haakensen, Vilde D., Lethiö, Janne, Papaleo, Elena, Gromova, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858121/ https://www.ncbi.nlm.nih.gov/pubmed/33176066 http://dx.doi.org/10.1002/1878-0261.12850 |
Ejemplares similares
-
Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration
por: Terkelsen, Thilde, et al.
Publicado: (2020) -
N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome
por: Terkelsen, Thilde, et al.
Publicado: (2018) -
Profiling of microRNAs in tumor interstitial fluid of breast tumors – a novel resource to identify biomarkers for prognostic classification and detection of cancer
por: Halvorsen, Ann Rita, et al.
Publicado: (2016) -
CAncer bioMarker Prediction Pipeline (CAMPP)—A standardized framework for the analysis of quantitative biological data
por: Terkelsen, Thilde, et al.
Publicado: (2020) -
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
por: Jabeen, Shakila, et al.
Publicado: (2018)